A resident of British Columbia has become the first person to be successfully cured of a rare disease using innovative prime editing technology. This method involves making precise changes to DNA without creating double-strand breaks, which reduces the likelihood of unexpected genetic disruptions. The application of this therapy helped him overcome a chronic granulomatous disease that previously required daily intake of antibiotics and antifungal medications.
Tai Sperl, who was diagnosed at the age of five, spent 14 years on continuous medication to manage his condition. Although a bone marrow transplant could have been a possible solution, a suitable donor could not be found during all this time, as reported by Global News.
Eventually, Tai was accepted into a pilot clinical trial aimed at studying the safety and efficacy of prime editing for treating rare genetic disorders. During the procedure, his blood stem cells were extracted, edited without using double-strand breaks, and then returned to his body.
The treatment results were impressive: immune function quickly restored, and the procedure itself was safe. In addition to Tai, another patient underwent similar treatment and also achieved full recovery.
“I always took a lot of pills, and now that’s in the past. I no longer need medication. It’s just incredible,” Tai shared his feelings.
Scientists consider these results an important step forward for medical science, opening new possibilities for families facing rare genetic diseases.
The post Canadian teenager becomes the first person cured by gene editing first appeared on the K-News website.
